Analytical Data
-
Gene name
C9orf23
- Application
-
Alternative Names
Rpp25-like protein
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N5L8
-
Expression Region
1-163aa
-
Molecular Weight
44.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C9orf23, located on chromosome 9, has garnered attention in recent years due to its potential implications in various biological processes and its association with human diseases. The protein encoded by the C9orf23 gene is believed to play a role in cellular functions, although its precise biological mechanisms remain largely unexplored. Initial studies suggest that C9orf23 may be involved in the regulation of gene expression and cellular signaling pathways. Research has indicated that alterations in C9orf23 expression may be linked to neurodegenerative disorders and certain types of cancers, thus making it a target of interest for therapeutic interventions. Furthermore, understanding the structure and function of the C9orf23 recombinant protein could provide insights into its role in health and disease, paving the way for the development of novel diagnostic and treatment strategies. Given the lack of comprehensive studies, further investigation into the biochemical properties and interaction networks of the C9orf23 protein is essential for elucidating its function and clinical relevance. This research could potentially reveal valuable information about its contribution to pathophysiological processes and open new avenues for targeted therapies.
